# CPT 55700

> Medicare paid $240.67 for CPT 55700 in the office (non-facility) setting and $128.49 in a facility under the Q4 2024 Physician Fee Schedule, effective October 2024. These are the national allowed amounts before the ~2% sequestration cut and before locality (GPCI) adjustment. This price has been unchanged since Q1 2024, when it decreased 1.5%.

## What it is

A needle biopsy of the prostate gland — one or more tissue samples taken through a needle or punch — most often performed to evaluate for prostate cancer.

## Selected release

- Release: Q4 2024 (2024 D)
- Effective: October 1 – December 31, 2024
- Status indicator: A
- Office (non-facility) national allowed amount: $240.67
- Facility national allowed amount: $128.49
- Sequestration: not applied

## RVUs and formula

- Work RVU: 2.50
- Office (non-facility) practice expense RVU: 4.42
- Facility practice expense RVU: 1.05
- Malpractice RVU: 0.31
- Conversion factor: 33.2875
- Formula: `(work_rvu × work_gpci + pe_rvu × pe_gpci + mp_rvu × mp_gpci) × conversion_factor`

## Source and citation

- Source: Physician relative value file (Q4 2024)
- CMS file: https://www.cms.gov/files/zip/rvu24d.zip
- Parsed file: PPRRVU24_OCT.csv, row 11,995
- Canonical page: https://localishealth.com/cpt/55700/2024/A
- Release-specific citation URL: https://localishealth.com/cpt/55700/2024/D
- Last significant update: 2026-08-04T03:14:25+00:00